Literature DB >> 21602030

Persistent psychosis following the use of Spice.

Nancy Van der Veer, Jason Friday.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21602030     DOI: 10.1016/j.schres.2011.04.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  14 in total

Review 1.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 2.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 3.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

Review 4.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

5.  Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients.

Authors:  Merih Altintas; Leman Inanc; Gamze Akcay Oruc; Selim Arpacioglu; Huseyin Gulec
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-02       Impact factor: 2.570

6.  First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone.

Authors:  Aaron J Roberto; Aileen Lorenzo; Kevin J Li; Jonathan Young; Abhishek Mohan; Subhash Pinnaka; Kyle A B Lapidus
Journal:  Case Rep Psychiatry       Date:  2016-06-26

7.  Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.

Authors:  Szilvia Kassai; Judit Nóra Pintér; József Rácz; Brigitta Böröndi; Tamás Tóth-Karikó; Kitti Kerekes; V Anna Gyarmathy
Journal:  Harm Reduct J       Date:  2017-02-10

Review 8.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

9.  Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations.

Authors:  Anahita Bassir Nia; Claire Mann; Harsimar Kaur; Mohini Ranganathan
Journal:  Curr Behav Neurosci Rep       Date:  2018-11-10

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.